Danimer Scientific, Inc.
DNMROTCBasic Materials
$0.35
+$0.00(+0.00%)
Market Cap$1056962
P/E Ratio—
52W High$1.85
52W Low$0.325
Danimer Scientific, Inc. (DNMR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DNMR · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Nov 19, 2024EPS Actual
-$0.24
Est. -$0.20 · -20.0%
Revenue
$0.01B
Est. $0.01B · -21.9%
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Nov 19, 2024
After Market Close
▼ Miss EPS▼ Miss Revenue
DNMR reports quarterly as a OTC-listed Chemicals - Specialty company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.20
Rev. $4.26B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.20
Rev. Est.$4.26B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 17, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 11, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 19, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 27, 2025 | -$6.12 | — | — | — | — | — |
| ▼ Q4 FY2024 | Nov 19, 2024 | -$0.20 | -$0.24 | -20.0% | $0.01B | $0.01B | -21.9% |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$9.60 | -$7.20 | +25.0% | $0.01B | $0.01B | -17.7% |
| ▲ Q2 FY2024 | May 7, 2024 | -$12.00 | -$10.40 | +13.3% | $0.01B | $0.01B | -7.6% |
| — Q1 FY2024 | Mar 28, 2024 | -$15.60 | -$15.60 | +0.0% | $0.01B | $0.01B | -3.4% |
Q4 FY2025
Nov 17, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 19, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 27, 2025
EPS Actual
—
EPS Est.
-$6.12
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 19, 2024Miss
EPS Actual
-$0.24
EPS Est.
-$0.20
EPS Surpr.
-20.0%
Revenue
$0.01B
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$7.20
EPS Est.
-$9.60
EPS Surpr.
+25.0%
Revenue
$0.01B
Q2 FY2024
May 7, 2024Beat
EPS Actual
-$10.40
EPS Est.
-$12.00
EPS Surpr.
+13.3%
Revenue
$0.01B
Q1 FY2024
Mar 28, 2024
EPS Actual
-$15.60
EPS Est.
-$15.60
EPS Surpr.
+0.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Q3 FY2026 | $-0.28 | $-0.28 | $-0.28 | 1 |
| Q2 FY2026 | $-0.33 | $-0.33 | $-0.33 | 1 |
| Q1 FY2026 | $-0.56 | $-0.56 | $-0.56 | 1 |
| Q4 FY2025 | $-3.67 | $-3.67 | $-3.67 | 1 |
| Q3 FY2025 | $-3.78 | $-3.78 | $-3.78 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2024 | Nov 19, 2024 | -20.0% | $8.04 | $6.13 | -23.76% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +25.0% | $16.41 | $18.48 | +12.61% |
| ▲ Q2 FY2024 | May 7, 2024 | +13.3% | $32.16 | $32.80 | +1.99% |
| ▲ Q1 FY2024 | Mar 28, 2024 | +0.0% | $45.20 | $43.60 | -3.54% |
| ▼ Q4 FY2023 | Nov 14, 2023 | -14.7% | $58.80 | $66.40 | +12.93% |
| ▼ Q3 FY2023 | Aug 8, 2023 | -5.6% | $99.60 | $100.00 | +0.40% |
| ▼ Q2 FY2023 | May 10, 2023 | -2.9% | $127.60 | $123.20 | -3.45% |
| ▲ Q1 FY2023 | Mar 28, 2023 | +6.7% | $108.00 | $112.00 | +3.70% |
Q4 FY2024-23.76%
Report Date
Nov 19, 2024
EPS Beat/Miss
-20.0%
Price Before
$8.04
Price After
$6.13
Q3 FY2024+12.61%
Report Date
Aug 8, 2024
EPS Beat/Miss
+25.0%
Price Before
$16.41
Price After
$18.48
Q2 FY2024+1.99%
Report Date
May 7, 2024
EPS Beat/Miss
+13.3%
Price Before
$32.16
Price After
$32.80
Q1 FY2024-3.54%
Report Date
Mar 28, 2024
EPS Beat/Miss
+0.0%
Price Before
$45.20
Price After
$43.60
Q4 FY2023+12.93%
Report Date
Nov 14, 2023
EPS Beat/Miss
-14.7%
Price Before
$58.80
Price After
$66.40
Q3 FY2023+0.40%
Report Date
Aug 8, 2023
EPS Beat/Miss
-5.6%
Price Before
$99.60
Price After
$100.00
Q2 FY2023-3.45%
Report Date
May 10, 2023
EPS Beat/Miss
-2.9%
Price Before
$127.60
Price After
$123.20
Q1 FY2023+3.70%
Report Date
Mar 28, 2023
EPS Beat/Miss
+6.7%
Price Before
$108.00
Price After
$112.00
Avg Beat Reaction+3.69%
Avg Miss Reaction-3.47%
Beat Rate4 / 8 quarters
Largest Move-23.76% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DNMR ends December
Danimer Scientific, Inc. (DNMR) most recently reported earnings on November 19, 2024 for Q4 FY2024, posting EPS of $-0.24 — missing the analyst consensus of $-0.20 by -20.0%. The next DNMR earnings date is expected around September 1, 2026.
Each quarter, investors track DNMR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DNMR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DNMR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DNMR earnings · 5 questionsDanimer Scientific, Inc.'s next earnings report is expected around September 1, 2026. DNMR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DNMR historically reports after market close (AMC).
DNMR earnings datewhen is DNMR earningsDNMR next earnings datewhen does DNMR report earningsDNMR earnings calendar
▸ Source: FMP · Danimer Scientific, Inc. SEC filings · US GAAP · Danimer Scientific, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026